Test Price
1,200 AED✅ Home Collection Available
PML::RARA t(15;17)(q22;q12) Gene Rearrangement Quantitative PCR Test in UAE | 1200 AED | 2026 DHA Guidelines
تحليل إعادة ترتيب جين PML::RARA الكمي بتفاعل البوليميراز المتسلسل (qPCR) في الإمارات | 1200 درهم | إرشادات هيئة الصحة بدبي 2026
Executive Summary: Achieve 99.9% diagnostic sensitivity for acute promyelocytic leukaemia (APL) monitoring and treatment guidance with our ISO-certified quantitative PCR. Premium hospital-grade home collection, VIP mobile phlebotomy, and direct insurance billing verification are included.
ملخص تنفيذي: اختبار دقيق بنسبة 99.9% لتشخيص ابيضاض الدم النقوي الحادّ (APL) ورصد الاستجابة للعلاج. نقدم خدمة سحب دم منزلي فاخرة، وفريق تمريض متنقل، مع إمكانية التحقق المباشر من تغطية التأمين الصحي.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity & 100% Specificity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) compliant qPCR.
- Premium Logistics: Paid Hospital-Grade Cold-Chain Home Collection (8 AM – 11 PM) & VIP Mobile Phlebotomy.
- Clinical Guidance: Complimentary Telephonic Post‑Test Clinical Result Interpretation by our DHA‑licensed team.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview
The PML::RARA qPCR test precisely quantifies the fusion transcript t(15;17) that defines acute promyelocytic leukaemia (APL), enabling early diagnosis and disease monitoring. It is essential for guiding targeted therapies (ATRA & arsenic trioxide) and detecting minimal residual disease.
| Parameter | Our PML::RARA qPCR | Closest Alternative (FISH / Cytogenetics) |
|---|---|---|
| Precision | Absolute quantification; sensitivity down to 1 abnormal cell in 104 | Qualitative or semi‑quantitative; 5-10% detection threshold |
| Methodology | Real‑Time Quantitative PCR (qPCR) with ISO‑certified standard curves | Fluorescence in‑situ Hybridisation (FISH) / Karyotyping |
| Turnaround Time | 2 business days (sample Mon/Wed/Fri by 9 AM → report Tue/Thu/Sat) | 5–10 calendar days |
| Clinical Utility | Diagnosis, remission assessment, MRD monitoring, resistance detection | Diagnosis only; limited for therapy monitoring |
Medical Expert Insight & Precautionary Protocol
“This highly sensitive qPCR assay is a cornerstone for managing APL. However, results must always be correlated with the patient’s clinical picture, coagulation profile, and bone marrow morphology. A negative result does not exclude malignancy if clinical suspicion remains high.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠ Do not discontinue prescribed medication without consulting your doctor.
Safety Exclusion Criteria & Emergency Red Flags
- The test is not indicated for individuals without clinical suspicion of APL or a known PML::RARA translocation.
- Do not submit if the patient is haemodynamically unstable or has active, uncontrolled bleeding.
- Pregnancy: Discuss risk‑benefit with your haematologist; genetic analysis requires specific counselling.
- Seek emergency care immediately if you experience: sudden bruising, petechiae, severe headache, shortness of breath, or any uncontrolled bleeding.
- A completed Genomics Clinical Information Requisition Form (Form 20) is mandatory. Incomplete forms will delay reporting.
Frequently Asked Questions
What is the PML::RARA gene rearrangement test?
This quantitative PCR test detects the fusion gene causing acute promyelocytic leukemia, vital for diagnosis and monitoring treatment response. يكشف هذا الاختبار الكمي عن جين الاندماج المسبّب لابيضاض الدم النقوي الحادّ، وهو ضروري للتشخيص ومتابعة الاستجابة للعلاج.
Why is this test performed?
It confirms acute promyelocytic leukemia, directs targeted therapy with ATRA and arsenic trioxide, and monitors remission. يؤكد تشخيص ابيضاض الدم النقوي الحادّ من النمط M3، ويوجّه العلاج الموجّه بحمض الريتينويك وثلاثي أكسيد الزرنيخ، ويرصد حالة الهجوع.
How should I prepare for the?
No fasting is needed; provide a blood sample and a completed Form 20; list current anticoagulant medications. لا حاجة للصيام؛ يتم تقديم عينة دم ونموذج 20 مكتمل مع ذكر أدوية منع التخثر الحالية.
Regulatory Compliance: All procedures abide by UAE Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minor Consent), UAE PDPL, and ISO 9001:2015. Facility License: 9834453. Laboratory certified by DHA/MOHAP.
Sample Logistics: 5 mL whole blood in 2 Lavender Top (EDTA) tubes, refrigerated (DO NOT FREEZE). Sample collection Mon/Wed/Fri before 9 AM; report next business day.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians